logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 인천지방법원 2016.11.28 2016고단7509
사기등
Text

A defendant shall be punished by imprisonment for one year.

The number of seized 240, the number of yellow caps 3,278, the number of caps 712, the number of caps 712.

Reasons

Punishment of the crime

1. No person who violates the Pharmaceutical Affairs Act may sell medicines or acquire them for the purpose of sale, other than a pharmacy founder;

Around August 2015, the Defendant, even if a pharmacy founder is not a pharmacy owner, agreed to sell a “balone,” which includes the substance of a medicine, which is a medicine prior to the generation donation, with her husband C, and C, upon receiving an order from the purchaser via the website (D) that it operated, provided the purchaser with the volume of the drug and the purchaser’s name, address, etc., and the Defendant was willing to deliver the two parts to the purchaser after receiving the name, address, etc. of the two parts from C.

Around October 1, 2015, the Defendant received from the Defendant’s house located in Yangcheon-gu Seoul E, 101 Dong 102 through mobile phones from C, and then distributed the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the f the

In addition, around September 2, 2016, the Defendant acquired and kept 240 of the total market price of 90,405,000 won for the purpose of sale in the above Defendant’s residence, 3,278 of the color caps (hereinafter “alley caps”), 712 of the color caps, 82 of the white caps, 779 of the color caps, 779 of the verification coloring, 100 of the drug “non clinic” and 864 of the color caps, including shot caps, for the purpose of sale in the above Defendant’s residence.

As a result, the Defendant, in collusion with C, sold a “balwing group” containing a drug substance of an amounting to KRW 55,090,000 in the market price, and acquired a “balwing group” and “balwing group” including a liver, liver, and liver component of KRW 90,405,00 in the market price for the purpose of sale.

2...

arrow